𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck

✍ Scribed by Reuter, C W M; Morgan, M A; Eckardt, A


Book ID
109999055
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
159 KB
Volume
96
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Targeted therapies in squamous cell carc
✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Epidermal growth factor receptor targete
✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR

Urokinase receptor up-regulation in head
✍ Marianne Schmidt; Gabriele Schler; Petra Gruensfelder; Justus MΓΌller; Florian Ho πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 288 KB πŸ‘ 2 views

Background. Urokinase-type plasminogen activator is important for matrix degradation and motility of cancer cells. For effective invasion, urokinase has to be associated with its cell surface receptor. 1 Methods. We analyzed 33 head and neck squamous cell carcinomas (hnSCC) and 14 mucosal tissue sam